| Factors associated with the prevalence of thyroid nodules and goiter in middle-aged euthyroid subjects D Dauksiene, J Petkeviciene, J Klumbiene, R Verkauskiene, ... International journal of endocrinology 2017, 2017 | 81 | 2017 |
| Association of microRNA Expression and BRAFV600E Mutation with Recurrence of Thyroid Cancer D Pamedytyte, V Simanaviciene, D Dauksiene, E Leipute, A Zvirbliene, ... Biomolecules 10 (4), 625, 2020 | 21 | 2020 |
| Different stability of miRNAs and endogenous control genes in archival specimens of papillary thyroid carcinoma D Pamedytyte, E Leipute, B Zilaitiene, V Sarauskas, D Dauksiene, ... Molecular medicine 26, 1-7, 2020 | 8 | 2020 |
| SAT-LB096 relationship between MicroRNA expression levels and clinicopathological parameters and recurrence of papillary thyroid carcinoma D Pamedytyte, V Simanaviciene, D Dauksiene, E Leipute, A Zvirbliene, ... Journal of the Endocrine Society 3 (Supplement_1), SAT-LB096, 2019 | 4 | 2019 |
| Diagnostic Value of Circulating Cell-free DNA in Patients With Papillary Thyroid Cancer R Klimaite, M Kazokaite, A Kondrotiene, D Dauksiene, R Verkauskiene, ... Anticancer Research 42 (5), 2289-2299, 2022 | 3 | 2022 |
| Transaxillary gasless endoscopic hemithyroidectomy versus conventional open hemithyroidectomy: early single-centre experience K Jasaitis, M Skimelyte, A Maleckas, D Dauksiene, V Krasauskas, ... Updates in Surgery 74 (3), 917-925, 2022 | 2 | 2022 |
| Corrigendum to “factors associated with the prevalence of thyroid nodules and goiter in middle-aged euthyroid subjects” D Dauksiene, J Petkeviciene, J Klumbiene, R Verkauskiene, ... International Journal of Endocrinology 2019, 2019 | 2 | 2019 |
| The relationship between TSHR methylation level and clinicopathological factors in papillary thyroid cancer R Klimaite, M Kazokaitė, A Kondrotienė, D Dauksiene, B Zilaitiene, ... Endocrine Abstracts 90, 2023 | | 2023 |
| The role of ACTB status for early non-invasive detection of papillary thyroid carcinoma R Klimaite, M Kazokaitė, A Kondrotienė, D Dauksiene, B Zilaitiene, ... Endocrine Abstracts 81, 2022 | | 2022 |
| The relationship between clinicopathological factors and recurrence risk of papillary thyroid cancer R Klimaite, D Dauksiene, A Dauksa, V Sarauskas, R Verkauskiene, ... Endocrine Abstracts 70, 2020 | | 2020 |
| Evaluation of miRNA-222,–146b,–181b as possible diagnostic markers in patients with papillary thyroid carcinoma A Kondrotiene, D Pamedytyte, V Simanaviciene, D Dauksiene, ... Endocrine Abstracts 70, 2020 | | 2020 |
| MON-LB82 Plasma Expression Level of MiRNA-21 Is Related With the Presence of Papillary Thyroid Cancer B Zilaitiene, A Kondrotiene, D Pamedytyte, V Simanaviciene, ... Journal of the Endocrine Society 4 (Supplement_1), MON-LB82, 2020 | | 2020 |
| Jelena Vainikonyte-Kristapone, 3 Audrone Seibokaite, Jonas Ceponis, Vygantas Sidlauskas, Laura Daugintyte-Petrusiene, 3 Antanas Norkus, and Birute Zilaitiene D Dauksiene, J Petkeviciene, J Klumbiene, R Verkauskiene | | 2019 |
| Relationship between microRNA expression levels and tumor size in patients with papillary thyroid carcinoma D Pamedytyte, V Simanaviciene, A Zvirbliene, M Kazokaite, V Sarauskas, ... Endocrine Abstracts 56, 2018 | | 2018 |
| The association of gene polymorphisms with the clinical outcome of Graves D Dauksiene, N Mickuviene, A Dauksa Endocrine Abstracts 49, 2017 | | 2017 |
| Expressions of miRNAs and BRAFV600E mutation detection in papillary thyroid carcinoma V Simanaviciene, A Kondrotiene, D Pamedytyte, V Sarauskas, ... Endocrine Abstracts 49, 2017 | | 2017 |
